Clayton R. Rowland - Concepedia

Concepedia

Author

Clayton R. Rowland

Novartis (United States)

Also Known As

C R Rowland, C.R. Rowland, Clayton R Rowland, Clayton R. Rowland

22

Publications

2.5K

Citations

12

H-Index

47

Concepts

All Affiliations

Novartis (United States)Kaiser Permanente Oakland Medical Center The Ohio State University Kaiser Permanente Brod Group

CR

About

Clayton R. Rowland is an author at Novartis (United States) specializing in medicine, health economics, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	280
2	Public Health	4	4	210
3	Health Sciences	2	2	33
4	Management	1	1	10
5	Nursing	1	1	14

Clayton R. Rowland

×

15

Publications

2.5K

Citations

12

H-Index

	Year	Citations
Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Mark J. Atkinson, Anusha Sinha, Steven Hass, Health and Quality of Life Outcomes	2004	939
The impact of depression on the academic productivity of university students. Alketa Hysenbegasi, Steven Hass, Clayton R. Rowland PubMed	2005	654
Economic costs of anxiety disorders Robert L. DuPont, Dorothy P. Rice, Leonard S. Miller, Anxiety	1996	318
Discontinuing or Switching Selective Serotonin-Reuptake Inhibitors Scott Bull, Enid M. Hunkeler, Janelle Y Lee, Annals of Pharmacotherapy	2002	185
Economic costs of obsessive-compulsive disorder. Randolph Dupont, Dorothy P. Rice, Sarah S. Shiraki, PubMed Psychological Co-morbiditiesHuman Capital ApproachPsychopathologyPsychiatryHealth Economics	1995	145
Oral Almotriptan vs Oral Sumatriptan in the Abortive Treatment of Migraine Egilius L.H. Spierings, Baltazar Gomez‐Mancilla, Daniel Grosz, Archives of Neurology	2001	82
Cost-benefit and cost-effectiveness: Methodologies for evaluating innovative pharmaceutical services William F. McGhan, Clayton R. Rowland, J. Lyle Bootman American Journal of Health-System Pharmacy Innovation EvaluationPharmacotherapyCost-effectiveness Analysis TechniquesPrimary CarePharmaceutical Service	1978	40
The importance of endogenous catecholamines in the activity of some CNS stimulants Harold H. Wolf, Douglas E. Rollins, Clayton R. Rowland, International Journal of Neuropharmacology Endogenous CatecholaminesNeurophysiologyMedicinePhysiologyNeurotransmitter	1969	23
Effect of some nonionic surfactants on the rate of release of drugs from suppositories James M. Plaxco, Clifford Free, Clayton R. Rowland Journal of Pharmaceutical Sciences Pharmaceutical ScienceMedicineNonionic SurfactantsPharmaceutical TechnologyDrug Delivery System	1967	20
Discontinuing or Switching Selective Serotonin-Reuptake Inhibitors Scott Bull, Enid M. Hunkeler, Janelle Y Lee, Annals of Pharmacotherapy Psychotropic MedicationPsychopharmacologyPharmacotherapyMental HealthSocial Sciences	2002	17

Page 1